Although the primary role of FGFR4 in metabolism occurs in hepatocytes, its ablation results in a net inhibitory effect on mammary tumour progression, most likely due to suppressing signals triggered by FGF21 from breast adipocytes [228]. Here, FGF21 is linked to breast cancer.